Murine dendritic cell development: Difficulties associated with subset analysis

Immunology and Cell Biology

Volumn 81, Issue 4, 2003, Pages 239-246

  Wilson, Heather L ^a   O'Neill, Helen C ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Cell development; Dendritic cells; Haemopoiesis; Lineage

Indexed keywords

CELL SURFACE MARKER;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; BONE MARROW CELL; CELL FUNCTION; CELL MATURATION; CELLULAR DISTRIBUTION; DENDRITIC CELL; HEMATOPOIESIS; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOID TISSUE; NONHUMAN; PLASTICITY; REVIEW; STEM CELL;

ANIMALS; ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL MOVEMENT; DENDRITIC CELLS; LYMPHOID TISSUE; MICE; MYELOID CELLS;

MURINAE;

EID: 0041846758     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2003.t01-1-01165.x     Document Type: Review

References (106)

1. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 1973; 137: 1142-62.
2. Mayordomo JI, Zorina T, Storkus WJ et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1995; 1: 1297-302.
3. Fields RC, Shimizu K, Mule JJ. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl Acad. Sci. USA 1998; 95: 9482-7.
4. Nestle FO, Alijagic S, Gilliet M et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 1998; 4: 328-32.
5. Reichardt VL, Okada CY, Liso A et al. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - a feasibility study. Blood 1999; 93: 2411-19.
6. Boczkowski D, Nair SK, Nam JH, Lyerly HK, Gilboa E. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer. Res. 2000; 60: 1028-34.
7. + cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int. Immunol. 1993; 5: 849-57.
8. + T cells. J. Clin. Invest. 1994; 94: 797-807.
9. Clare-Salzler MJ, Brooks J, Chai A, Van Herle K, Anderson C. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J. Clin. Invest. 1992; 90: 741-8.
10. De Panfilis G, Manara GC, Ferrari C, Torresani C. Simultaneous colloidal gold immunoelectronmicroscopy labeling of CD1a, HLA-DR, and CD4 surface antigens of human epidermal Langerhans cells. J. Invest. Dermatol. 1988; 91: 547-52.
11. Borkowski TA, Van Dyke BJ, Schwarzenberger K, McFarland VW, Farr AG, Udey MC. Expression of E-cadherin by murine dendritic cells: E-cadherin as a dendritic cell differentiation antigen characteristic of epidermal Langerhans cells and related cells. Eur. J. Immunol. 1994; 24: 2767-74.
12. Valladeau J, Duvert-Frances V, Pin J-J et al. The monoclonal antibody DCGM4 recognises langerin, a protein specific of langerhans cells, and is rapidly internalized from the cell surface. Eur. J. Immunol. 1999; 29: 2695-704.
13. Birbeck MS, Breathnach AS, Everall JD. An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J. Invest. Dermatol. 1961; 37: 51-64.
14. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 2000; 164: 2978-86.
15. Henri S, Vremec D, Kamath A et al. The dendritic cell populations of mouse lymph nodes. J. Immunol. 2001; 167: 741-8.
16. - dendritic cells in the induction of primary immune responses in vivo. J. Leukoc. Biol. 1999; 66: 242-6.
17. + dendritic cells. J. Immunol. 2001; 166: 5327-30.
18. Carlow DA, van Oers NS, Teh SJ, Teh HS. Deletion of antigen-specific immature thymocytes by dendritic cells requires LFA-1/ICAM interactions. J. Immunol. 1992; 148: 1595-603.
19. Brocker T, Riedinger M, Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 1997; 185: 541-50.
20. Nijman HW, Kleijmeer MJ, Ossevoort MA et al. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. J. Exp. Med. 1995; 182: 163-74.
21. Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997; 90: 3245-87.
22. Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 1990; 171: 1753-71.
23. Crowley M, Inaba K, Steinman RM. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J. Exp. Med. 1990; 172: 383-6.
24. Leenen PJM, Radosevic K, Voerman JSA et al. Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover. J. Immunol. 1998; 160: 2166-73.
25. Kraal G, Breel M, Janse M, Bruin G. Langerhans cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 1986; 163: 981-97.
26. Inaba K, Swiggard WJ, Inaba M et al. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. Cell. Immunol. 1995; 163: 148-56.
27. Jiang W, Swiggard WJ, Heufler C et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995; 375: 151-5.
28. Coates JP, Rowland S, Hill S et al. Comparison between the phenotype and function of maturing dendritic cells from spleen and lymph nodes. Immunology 1996; 89: 457-62.
29. Pierre P, Turley SJ, Gatti E et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997; 388: 787-92.
30. Nussenzweig MC, Steinman RM, Witmer MD, Gutchinov B. A monoclonal antibody specific for mouse dendritic cells. Proc. Natl Acad. Sci. USA 1982; 79: 161-5.
31. + T lymphocytes to peptide antigen in vivo. J. Immunol. 1993; 151: 6742-50.
32. + Th1 and Th2 cells by blood dendritic cells. Scand. J. Immunol. 1996; 43: 646-51.
33. + T cells. J. Exp. Med. 1997; 185: 2133-41.
34. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 2002; 195: 343-51.
35. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 2002; 195: 327-33.
36. Dubois B, Vanbervliet B, Fayette J et al. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 1997; 185: 941-51.
37. Kushnir N, Liu L, MacPherson GG. Dendritic cells and resting B cells form clusters in vitro and in vivo: T cell independence, partial LFA-1 dependence, and regulation by cross-linking surface molecules. J. Immunol. 1998; 160: 1774-81.
38. Wykes M, Pombo A, Jenkins C, MacPherson GG. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol. 1998; 161: 1313-19.
39. Litinskiy MB, Nardelli B, Hilbert DM et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 2002; 3: 822-9.
40. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 1995; 182: 389-400.
41. De Smedt T, Pajak B, Muraille E et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 1996; 184: 1413-24.
42. Sparwasser T, Koch ES, Vabulas RM et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 1998; 28: 2045-54.
43. Vecchi A, Massimiliano L, Ramponi S et al. Differential responsiveness to constitutive vs inducible chemokines of immature and mature mouse dendritic cells. J. Leukoc. Biol. 1999; 66: 489-94.
44. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 2000; 191: 423-34.
45. Hochrein H, Shortman K, Vremec D, Scott B, Hertzog P, O'Keeffe M. Differential production of IL-12, IFN-α, and IFN-γ by mouse dendritic cell subsets. J. Immunol. 2001; 166: 5448-55.
46. + T cells. J. Immunol. 1999; 162: 5287-98.
47. Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 2001; 194: 769-79.
48. + regulatory T cells in vivo in humans. Blood 2002; 100: 174-7.
49. Fazekas de St Groth B. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol. Today 1998; 19: 448-54.
50. + dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 2002; 196: 1099-104.
51. Legge KL, Gregg RK, Maldonado-Lopez R et al. On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J. Exp. Med. 2002; 196: 217-27.
52. Lutz M, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 2002; 23: 445.
53. Albert ML, Pearce SFA, Francisco LM et al. Immature dendritic cells phagocytose apoptotic cells via avb5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 1998; 188: 1359-68.
54. Kurts C, Cannarile M, Klebba I, Brocker T. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 2001; 166: 1439-42.
55. + T cells. Nat. Immunol. 2001; 2: 1010-17.
56. Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994; 264: 961-5.
57. Green DR, Beere HM. Apoptosis: Gone but not forgotten. Nature 2000; 405: 28-9.
58. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106: 255-8.
59. + cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 2001; 194: 1171-8.
60. + cells in murine bone marrow and spleen does not belong to the B cell lineage but has dendritic cell characteristics. Eur. J. Immunol. 2002; 32: 686-92.
61. + dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 2002; 100: 383-90.
62. Pulendran B, Lingappa J, Kennedy MK et al. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol. 1997; 159: 2222-31.
63. Crowley M, Inaba K, Witmer-Pack M, Steinman RM. The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus. Cell. Immunol. 1989; 118: 108-25.
64. Vremec D, Shortman K. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 1997; 159: 565-73.
65. + dendritic cells and antigen-specific CD4 T cells after subcutaneous injection of antigen. J. Immunol. 2002; 169: 2247-52.
66. Suss G, Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 1996; 183: 1789-96.
67. Kronin V, Winkel K, Suss G et al. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J. Immunol. 1996; 157: 3819-27.
68. Pulendran B, Smith JL, Caspary G et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl Acad. Sci. USA 1999; 96: 1036-41.
69. - dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 2000; 192: 1685-96.
70. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 1999; 189: 587-92.
71. Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 2001; 276: 37 692-9.
72. Kadowaki N, Ho S, Antonenko S et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001; 194: 863-9.
73. Krug A, Towarowski A, Britsch S et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 2001; 31: 3026-37.
74. Ito T, Amakawa R, Kaisho T et al. Interferon-α and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med. 2002; 195: 1507-12.
75. 2 regulates the migratory capacity of specific DC subsets. Blood 2002; 100: 1362-72.
76. Scandella E, Men Y, Gillessen S, Forster R, Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 2002; 100: 1354-61.
77. Manz MG, Traver D, Miyamoto T, Weissman IL, Akashi K. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 2001; 97: 3333-41.
78. + bone marrow hematopoietic progenitor cells. Blood 1998; 92: 118-28.
79. + hematopoietic progenitor cells. Blood 2000; 95: 138-46.
80. Schreurs MW, Eggert AA, de Boer AJ, Figdor CG, Adema GJ. Generation and functional characterization of mouse monocyte-derived dendritic cells. Eur. J. Immunol. 1999; 29: 2835-41.
81. Ardavin C, Wu L, Li CL, Shortman K. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature 1993; 362: 761-3.
82. del Hoyo GM, Martin P, Vargas HH, Ruiz S, Arias CF, Ardavin C. Characterization of a common precursor population for dendritic cells. Nature 2002; 415: 1043-7.
83. + dendritic cells. Blood 2002; 100: 569-77.
84. Kamath AT, Pooley J, O'Keeffe MA et al. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 2000; 165: 6762-70.
85. Wu L, Scollay R, Egerton M, Pearse M, Spangrude GJ, Shortman K. CD4 expressed on earliest T-lineage precursor cells in the adult murine thymus. Nature 1991; 349: 71-4.
86. Saunders D, Lucas K, Ismaili J et al. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1996; 184: 2185-96.
87. low lymphoid-committed precursors. Blood 2000; 96: 2511-19.
88. + dendritic cells. Immunity 1998; 9: 839-47.
89. Anderson KL, Perkin H, Surh CD, Venturini S, Maki RA, Torbett BE. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J. Immunol. 2000; 164: 1855-61.
90. + dendritic cells from a common myeloid progenitor. Science 2000; 290: 2152-4.
91. Ardavin C, Martinez del Hoyo G, Martin P et al. Origin and differentiation of dendritic cells. Trends Immunol. 2001; 22: 691-700.
92. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997; 91: 661-72.
93. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000; 404: 193-7.
94. Wu L, D'Amico A, Hochrein H, O'Keeffe M, Shortman K, Lucas K. Development of thymic and splenic dendritic cell populations from different hemopoietic precursors. Blood 2001; 98: 3376-82.
95. + dendritic cells in vivo. Blood 2000; 96: 1865-72.
96. Brasel K, De Smedt T, Smith JL, Maliszewski CR. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 2000; 96: 3029-39.
97. - dendritic cell subset by a maturation process involving CD8α, DEC-205, and CD24 up-regulation. Blood 2002; 99: 999-1004.
98. Kucharzik T, Hudson JT 3rd, Waikel RL, Martin WD, Williams IR. CCR6 expression distinguishes mouse myeloid and lymphoid dendritic cell subsets: demonstration using a CCR6 EGFP knock-in mouse. Eur. J. Immunol. 2002; 32: 104-12.
99. Carramolino L, Kremer L, Goya I et al. Down-regulation of the beta-chemokine receptor CCR6 in dendritic cells mediated by TNF-α and IL-4. J. Leukoc. Biol. 1999; 66: 837-44.
100. Yrlid U, Wick MJ. Antigen presentation capacity and cytokine production by murine splenic dendritic cell subsets upon Salmonella encounter. J. Immunol. 2002; 169: 108-16.
101. d'Ostiani CF, Del Sero G, Bacci A et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 2000; 191: 1661-74.
102. Edwards AD, Manickasingham SP, Sporri R et al. Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J. Immunol. 2002; 169: 3652-60.
103. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 1999; 5: 1249-55.
104. + dendritic cells (DC) veto cells'? The role of CD8 on DC in DC development and in the regulation of CD4 and CD8 T cell responses. Int. Immunol. 1997; 9: 1061-4.
105. Ahn JH, Lee Y, Jeon C et al. Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis. Blood 2002; 100: 1742-54.
106. Rissoan MC, Duhen T, Bridon JM et al. Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood 2002; 100: 3295-303.